Low-Grade Invasive Triple Negative Breast Carcinoma
Journal of Clinical and Translational Pathology · 2022
DOI: 10.14218/jctp.2022.00010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical and Translational Pathology, 2022. Verfasst von Nada Shaker und 3 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Triple-negative breast carcinomas (TNBCs) are defined as estrogen receptor-negative, progesterone receptor-negative, and human epidermal growth factor receptor 2-negative breast carcinomas and are composed of a heterogeneous group of breast carcinomas with most of them having aggressive behavior and poor prognosis. However, some TNBC cases are low grade with indolent clinical outcome and low risk of metastasis to other organs or regional lymph nodes. Low-grade TNBCs include low-grade adenosquamous carcinoma, fibromatosis-like metaplastic carcinoma, low-grade invasive (ductal or lobular) carcinoma with apocrine differentiation, classic adenoid cystic carcinoma, secretory carcinoma, tall cell carcinoma with reversed polarity, acinic cell carcinoma, and low-grade mucoepidermoid carcinoma. This review aims to summarize the clinicopathological correlation and the molecular features of low-grade special TNBC subtypes.
Zitieren
APA
Shaker, N., Ding, Q., Wang, Y., & Li, Z. (2022). Low-Grade Invasive Triple Negative Breast Carcinoma. Journal of Clinical and Translational Pathology. https://doi.org/10.14218/jctp.2022.00010
Vancouver
Shaker N, Ding Q, Wang Y, Li Z. Low-Grade Invasive Triple Negative Breast Carcinoma. Journal of Clinical and Translational Pathology. 2022. doi:10.14218/jctp.2022.00010
BibTeX
@article{Shaker2022,
author = {Shaker, Nada and Ding, Qingqing and Wang, Yihong and Li, Zaibo},
title = {Low-Grade Invasive Triple Negative Breast Carcinoma},
journal = {Journal of Clinical and Translational Pathology},
year = {2022},
doi = {10.14218/jctp.2022.00010}
}
EUVIMED